Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03135769
Title Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias (TROPHIMMUN)
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Hospices Civils de Lyon
Indications

gestational trophoblastic neoplasm

Therapies

Avelumab

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.